|
AU2009333559B2
(en)
|
2008-12-09 |
2015-03-12 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors
|
|
US8338441B2
(en)
*
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
|
AP2013006706A0
(en)
|
2010-07-02 |
2013-02-28 |
Gilead Sciences Inc |
Napht-2-ylacetic acid derivatives to treat AIDS
|
|
PH12013500015A1
(en)
|
2010-07-02 |
2013-02-18 |
Gilead Sciences Inc |
2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
|
|
US8633200B2
(en)
|
2010-09-08 |
2014-01-21 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
JP2014511859A
(ja)
*
|
2011-04-04 |
2014-05-19 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖインテグラーゼ阻害剤の調製のためのプロセス
|
|
EP2508511A1
(en)
|
2011-04-07 |
2012-10-10 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2511273B8
(en)
|
2011-04-15 |
2019-06-26 |
Hivih |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
UA111841C2
(uk)
|
2011-04-21 |
2016-06-24 |
Гіліад Сайєнсіз, Інк. |
Сполуки бензотіазолу та їх фармацевтичне застосування
|
|
ES2553449T3
(es)
|
2011-07-06 |
2015-12-09 |
Gilead Sciences, Inc. |
Compuestos para el tratamiento de VIH
|
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
CN102952069B
(zh)
*
|
2011-08-19 |
2014-12-17 |
中国科学技术大学 |
一种化合物及其制备方法和应用
|
|
AP2014007595A0
(en)
*
|
2011-09-30 |
2014-04-30 |
Kineta Inc |
Anti-viral compounds
|
|
WO2013062028A1
(ja)
|
2011-10-25 |
2013-05-02 |
塩野義製薬株式会社 |
Ｈｉｖ複製阻害剤
|
|
CN104066732B
(zh)
|
2011-11-15 |
2016-04-13 |
韩国化学硏究院 |
新型抗病毒吡咯并吡啶衍生物及其制备方法
|
|
US9376392B2
(en)
|
2012-01-04 |
2016-06-28 |
Gilead Sciences, Inc. |
2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
|
|
WO2013103738A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Napthalene acetic acid derivatives against hiv infection
|
|
US8629276B2
(en)
|
2012-02-15 |
2014-01-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9096586B2
(en)
|
2012-04-20 |
2015-08-04 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
US8906929B2
(en)
*
|
2012-08-16 |
2014-12-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
EP2716639A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2716632A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2719685A1
(en)
|
2012-10-11 |
2014-04-16 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
US9012441B2
(en)
|
2013-01-09 |
2015-04-21 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
CA2896244C
(en)
|
2013-01-09 |
2017-07-04 |
Gilead Sciences, Inc. |
5-membered heteroaryls and their use as antiviral agents
|
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
|
TW201441197A
(zh)
|
2013-01-31 |
2014-11-01 |
Shionogi & Co |
Ｈｉｖ複製抑制劑
|
|
TWI694071B
(zh)
|
2013-03-01 |
2020-05-21 |
美商基利科學股份有限公司 |
治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
|
|
JP2016512507A
(ja)
*
|
2013-03-13 |
2016-04-28 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ヒト免疫不全ウイルス複製の阻害剤
|
|
US9663536B2
(en)
|
2013-03-13 |
2017-05-30 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
US9580431B2
(en)
|
2013-03-13 |
2017-02-28 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
EP2970274B1
(en)
*
|
2013-03-14 |
2017-03-01 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
JP6268656B2
(ja)
|
2013-03-14 |
2018-01-31 |
ビーブ・ヘルスケア・ユーケイ・（ナンバー５）・リミテッドＶｉｉＶ Ｈｅａｌｔｈｃａｒｅ ＵＫ （Ｎｏ．５） Ｌｉｍｉｔｅｄ |
ヒト免疫不全ウイルス複製の阻害剤
|
|
EP2821104A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2821082A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
|
|
DK3019503T3
(da)
|
2013-07-12 |
2017-11-20 |
Gilead Sciences Inc |
Polycykliske-carbamoylpyridon-forbindelser og anvendelse deraf til behandling af hiv-infektioner
|
|
NO2865735T3
(enExample)
|
2013-07-12 |
2018-07-21 |
|
|
|
EP3041849A4
(en)
|
2013-09-05 |
2017-04-19 |
Dow AgroSciences LLC |
Methods for producing borylated arenes
|
|
ES2654242T3
(es)
|
2014-02-12 |
2018-02-12 |
Viiv Healthcare (No.5) Limited |
Macrociclos de benzotiazol como inhibidores de la réplica del virus de la inmunodeficiencia humana
|
|
US9409922B2
(en)
|
2014-02-18 |
2016-08-09 |
Bristol-Myers Squibb Company |
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
|
|
EP3107913B1
(en)
|
2014-02-19 |
2018-07-04 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
US9193720B2
(en)
|
2014-02-20 |
2015-11-24 |
Bristol-Myers Squibb Company |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
PT3116880T
(pt)
|
2014-02-20 |
2018-05-10 |
Viiv Healthcare Uk No 5 Ltd |
Macrociclos de ácido piridin-3-il acético como inibidores da replicação do vírus da imunodeficiência humana
|
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
WO2015174511A1
(ja)
|
2014-05-16 |
2015-11-19 |
塩野義製薬株式会社 |
Ｈｉｖ複製阻害作用を有する３環性複素環誘導体
|
|
TW201625354A
(zh)
|
2014-06-16 |
2016-07-16 |
陶氏農業科學公司 |
用於製備氧硼基化芳烴之方法
|
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
|
NO2717902T3
(enExample)
|
2014-06-20 |
2018-06-23 |
|
|
|
LT3166925T
(lt)
|
2014-07-08 |
2018-06-11 |
Viiv Healthcare Uk Limited |
Izoindolino dariniai, skirti panaudoti virusinės infekcijos gydymui
|
|
TWI733652B
(zh)
|
2014-07-11 |
2021-07-21 |
美商基利科學股份有限公司 |
用於治療ＨＩＶ之ｔｏｌｌ樣受體調節劑
|
|
KR20170032324A
(ko)
*
|
2014-07-21 |
2017-03-22 |
비이브 헬쓰케어 유케이 리미티드 |
항-hiv 효과를 갖는 페닐 및 터트부틸아세트산 치환된 피리디논
|
|
CA2958591A1
(en)
|
2014-08-27 |
2016-03-03 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
US20160067255A1
(en)
|
2014-09-04 |
2016-03-10 |
Gilead Sciences, Inc. |
Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
|
|
JP2017526730A
(ja)
|
2014-09-16 |
2017-09-14 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｔｏｌｌ様受容体モジュレーターの固体形態
|
|
TWI738321B
(zh)
|
2014-12-23 |
2021-09-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
|
EP3237397B1
(en)
|
2014-12-24 |
2018-11-21 |
Gilead Sciences, Inc. |
Isoquinoline compounds for the treatment of hiv
|
|
ES2735087T3
(es)
|
2014-12-24 |
2019-12-16 |
Gilead Sciences Inc |
Compuestos de pirimidina fusionados para el tratamiento de VIH
|
|
TW202237569A
(zh)
|
2014-12-24 |
2022-10-01 |
美商基利科學股份有限公司 |
喹唑啉化合物
|
|
DK3097102T3
(en)
|
2015-03-04 |
2018-01-22 |
Gilead Sciences Inc |
TOLL-LIKE RECEPTOR MODULATING 4,6-DIAMINO-PYRIDO [3,2-D] PYRIMIDINE COMPOUNDS
|
|
TR201905009T4
(tr)
|
2015-04-02 |
2019-05-21 |
Gilead Sciences Inc |
Polisiklik-karbamoilpiridon bileşikleri ve bunların farmasötik kullanımları.
|
|
EP3305789A4
(en)
|
2015-05-29 |
2018-11-21 |
Shionogi & Co., Ltd. |
Nitrogen-containing tricyclic derivative having hiv replication inhibitory activity
|
|
KR20180025928A
(ko)
*
|
2015-07-06 |
2018-03-09 |
비브 헬스케어 유케이 (넘버5) 리미티드 |
인간 면역결핍 바이러스 복제의 억제제로서 피리딘-3-일 아세트산 유도체
|
|
AU2016290151A1
(en)
*
|
2015-07-08 |
2018-01-18 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-YL acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
WO2017006281A1
(en)
|
2015-07-09 |
2017-01-12 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
BR112018000253A2
(pt)
*
|
2015-07-09 |
2018-09-04 |
Viiv Healthcare Uk No 5 Ltd |
composto, composição, e, método para tratar a infecção pelo hiv.
|
|
EP3331868A1
(en)
|
2015-08-07 |
2018-06-13 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
EP3334741A1
(en)
|
2015-08-10 |
2018-06-20 |
VIIV Healthcare UK (No.5) Limited |
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
|
|
TWI657086B
(zh)
*
|
2015-08-11 |
2019-04-21 |
英商Viiv醫療保健英國(No.5)有限公司 |
做為人類免疫缺陷病毒複製抑制劑之５－（ｎ－苯甲基四氫異喹啉－６－基）吡啶－３－基乙酸衍生物
|
|
CA2995087A1
(en)
|
2015-08-12 |
2017-02-16 |
John F. Kadow |
5-(n-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
TW201718537A
(zh)
*
|
2015-08-12 |
2017-06-01 |
Ｖｉｉｖ醫療保健英國（Ｎｏ．５）有限公司 |
做為人類免疫缺陷病毒複製抑制劑之吡啶－３－基乙酸衍生物
|
|
KR20180032650A
(ko)
*
|
2015-08-12 |
2018-03-30 |
비브 헬스케어 유케이 (넘버5) 리미티드 |
인간 면역결핍 바이러스 복제의 억제제로서 5-(n-[6,5]-융합된 바이사이클릭 아릴 테트라하이드로이소퀴놀린-6-일) 피리딘-3-일 아세트산 유도체
|
|
KR20180038047A
(ko)
*
|
2015-08-20 |
2018-04-13 |
비브 헬스케어 유케이 (넘버5) 리미티드 |
인간 면역결핍 바이러스 복제의 억제제로서 피리딘-3-일 아세트산 유도체
|
|
JP2018525412A
(ja)
|
2015-08-26 |
2018-09-06 |
ギリアード サイエンシーズ， インコーポレイテッド |
重水素化トール様受容体調節因子
|
|
JP2018527366A
(ja)
|
2015-09-15 |
2018-09-20 |
ギリアード サイエンシーズ， インコーポレイテッド |
ＨＩＶを処置するためのｔｏｌｌ様レセプターのモジュレーター
|
|
JP2018529714A
(ja)
|
2015-09-30 |
2018-10-11 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖの処置のための化合物および組合せ物
|
|
ES2928164T3
(es)
*
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
MD3377488T2
(ro)
*
|
2015-11-19 |
2023-02-28 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
|
JP2018536001A
(ja)
|
2015-12-04 |
2018-12-06 |
ヴィーブ ヘルスケア ユーケー リミテッド |
イソインドリン誘導体
|
|
PL3390441T3
(pl)
|
2015-12-15 |
2022-01-10 |
Gilead Sciences, Inc. |
Przeciwciała neutralizujące ludzki wirus niedoboru odporności
|
|
MA44075A
(fr)
|
2015-12-17 |
2021-05-19 |
Incyte Corp |
Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
|
|
MY199705A
(en)
|
2015-12-22 |
2023-11-20 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
WO2017192961A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
US20190152957A1
(en)
|
2016-05-11 |
2019-05-23 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
EP3455217A1
(en)
|
2016-05-11 |
2019-03-20 |
ViiV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
EP3455215A1
(en)
|
2016-05-11 |
2019-03-20 |
ViiV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
KR102685249B1
(ko)
|
2016-06-20 |
2024-07-17 |
인사이트 코포레이션 |
면역조절제로서의 복소환식 화합물
|
|
KR102401963B1
(ko)
*
|
2016-06-27 |
2022-05-25 |
케모센트릭스, 인크. |
면역조절제 화합물
|
|
EP3483142B1
(en)
|
2016-07-05 |
2025-10-15 |
Beijing Maxinovel Pharmaceuticals Co., Ltd. |
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
TW202138365A
(zh)
|
2016-08-19 |
2021-10-16 |
美商基利科學股份有限公司 |
治療性化合物
|
|
WO2018044783A1
(en)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018042331A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
|
WO2018042332A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
MA46093A
(fr)
|
2016-09-02 |
2021-05-19 |
Gilead Sciences Inc |
Composés modulateurs du recepteur de type toll
|
|
WO2018051250A1
(en)
|
2016-09-14 |
2018-03-22 |
Viiv Healthcare Company |
Combination comprising tenofovir alafenamide, bictegravir and 3tc
|
|
US10800772B2
(en)
|
2016-09-28 |
2020-10-13 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
US10407438B2
(en)
|
2016-10-27 |
2019-09-10 |
Gilead Sciences, Inc. |
Crystalline forms of darunavir
|
|
EP3558973B1
(en)
|
2016-12-22 |
2021-09-15 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
CA3047991A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
PE20191532A1
(es)
|
2016-12-22 |
2019-10-23 |
Incyte Corp |
Compuestos heterociclicos como inmunomoduladores
|
|
WO2018119224A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
|
EP3558989B1
(en)
|
2016-12-22 |
2021-04-14 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
TW201835068A
(zh)
|
2017-01-03 |
2018-10-01 |
英商Viiv醫療保健英國(No.5)有限公司 |
作為人類免疫缺乏病毒複製之抑制劑之吡啶-3-基乙酸衍生物
|
|
WO2018127801A1
(en)
|
2017-01-03 |
2018-07-12 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
AR110768A1
(es)
|
2017-01-31 |
2019-05-02 |
Gilead Sciences Inc |
Formas cristalinas de tenofovir alafenamida
|
|
AR110922A1
(es)
|
2017-02-06 |
2019-05-15 |
Gilead Sciences Inc |
Compuestos inhibidores del vih
|
|
JP7179028B2
(ja)
*
|
2017-06-14 |
2022-11-28 |
バイエル・アクチエンゲゼルシヤフト |
３，４－ジクロロ－ｎ－（２－シアノフェニル）－５－イソチアゾールカルボキサミドの製造方法
|
|
TWI728250B
(zh)
|
2017-06-21 |
2021-05-21 |
美商基利科學股份有限公司 |
靶向hiv gp120及cd3之多特異性抗體
|
|
CN110958883A
(zh)
|
2017-06-30 |
2020-04-03 |
Viiv保健公司 |
组合及其用途和疗法
|
|
MA49701A
(fr)
|
2017-07-28 |
2020-06-03 |
Chemocentryx Inc |
Composés immunomodulateurs
|
|
EP3661937B1
(en)
|
2017-08-01 |
2021-07-28 |
Gilead Sciences, Inc. |
Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections
|
|
CN111225665B
(zh)
|
2017-08-08 |
2023-12-08 |
凯莫森特里克斯股份有限公司 |
大环免疫调节剂
|
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
|
TWI687415B
(zh)
|
2017-08-17 |
2020-03-11 |
美商基利科學股份有限公司 |
Hiv蛋白質膜抑制劑之固體形式
|
|
JP6934562B2
(ja)
|
2017-08-22 |
2021-09-15 |
ギリアード サイエンシーズ， インコーポレイテッド |
治療用複素環式化合物
|
|
JOP20180092A1
(ar)
|
2017-10-13 |
2019-04-13 |
Gilead Sciences Inc |
مثبطات hiv بروتياز
|
|
US20190151307A1
(en)
|
2017-10-24 |
2019-05-23 |
Gilead Sciences, Inc. |
Methods of treating patients co-infected with a virus and tuberculosis
|
|
KR102492187B1
(ko)
|
2017-12-20 |
2023-01-27 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
Sting 어댑터 단백질을 활성화하는 포스포네이트 결합을 가진 3'3' 사이클릭 다이뉴클레오티드
|
|
JP7098748B2
(ja)
|
2017-12-20 |
2022-07-11 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール，ヴイ．ヴイ．アイ． |
Ｓｔｉｎｇアダプタータンパク質を活性化するホスホン酸結合を有する２’３’環状ジヌクレオチド
|
|
EP3733659B1
(en)
|
2017-12-29 |
2023-12-20 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd. |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|
|
CN111615391B
(zh)
|
2018-01-19 |
2023-05-30 |
吉利德科学公司 |
比卡格韦的代谢物
|
|
CN111836805B
(zh)
|
2018-02-15 |
2023-07-14 |
吉利德科学公司 |
吡啶衍生物及其用于治疗hiv感染的用途
|
|
TWI745652B
(zh)
|
2018-02-16 |
2021-11-11 |
美商基利科學股份有限公司 |
用於製備有療效化合物之方法及中間物
|
|
US10568874B2
(en)
|
2018-02-22 |
2020-02-25 |
Chemocentryx, Inc. |
Indane-amines as PD-L1 antagonists
|
|
RS64055B1
(sr)
|
2018-03-30 |
2023-04-28 |
Incyte Corp |
Heterociklična jedinjenja kao imunomodulatori
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
|
MD3790877T2
(ro)
|
2018-05-11 |
2023-08-31 |
Incyte Corp |
Derivați de tetrahidro-imidazo[4,5-c]piridină în calitate de imunomodulatori PD-L1
|
|
WO2019244066A2
(en)
|
2018-06-19 |
2019-12-26 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
WO2020003093A1
(en)
|
2018-06-25 |
2020-01-02 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
HUE071524T2
(hu)
|
2018-07-03 |
2025-09-28 |
Gilead Sciences Inc |
HIV GP120-at célzó antitestek és alkalmazási eljárások
|
|
CA3104398A1
(en)
|
2018-07-06 |
2020-01-09 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
|
CN112384505B
(zh)
|
2018-07-06 |
2025-05-27 |
吉利德科学公司 |
治疗性的杂环化合物
|
|
US11944611B2
(en)
|
2018-07-16 |
2024-04-02 |
Gilead Sciences, Inc. |
Capsid inhibitors for the treatment of HIV
|
|
TWI829205B
(zh)
|
2018-07-30 |
2024-01-11 |
美商基利科學股份有限公司 |
抗hiv化合物
|
|
KR20250161656A
(ko)
|
2018-09-19 |
2025-11-17 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 예방용 인테그라제 억제제
|
|
EP3860717A1
(en)
|
2018-10-03 |
2021-08-11 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
WO2020092528A1
(en)
|
2018-10-31 |
2020-05-07 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
|
PE20211655A1
(es)
|
2018-10-31 |
2021-08-24 |
Gilead Sciences Inc |
Compuestos de 6-azabencimidazol sustituidos como inhibidores de hpk1
|
|
WO2020176510A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
|
WO2020176505A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
|
CN113543851B
(zh)
|
2019-03-07 |
2025-03-18 |
捷克共和国有机化学与生物化学研究所 |
2’3’-环二核苷酸及其前药
|
|
WO2020178770A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
IL286328B1
(en)
|
2019-03-22 |
2026-04-01 |
Gilead Sciences Inc |
Tricyclic bridging compounds of carbamoylpyridone and their pharmaceutical use
|
|
WO2020214647A1
(en)
|
2019-04-17 |
2020-10-22 |
Gilead Sciences, Inc. |
Solid forms of an hiv protease inhibitor
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202104210A
(zh)
|
2019-04-17 |
2021-02-01 |
美商基利科學股份有限公司 |
Hiv蛋白酶抑制劑
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI762925B
(zh)
|
2019-05-21 |
2022-05-01 |
美商基利科學股份有限公司 |
鑑別對使用gp120 v3聚醣導向之抗體的治療敏感之hiv病患的方法
|
|
KR20220011685A
(ko)
|
2019-05-22 |
2022-01-28 |
길리애드 사이언시즈, 인코포레이티드 |
Tlr7 조절 화합물과 hiv 백신의 조합
|
|
TWI826690B
(zh)
|
2019-05-23 |
2023-12-21 |
美商基利科學股份有限公司 |
經取代之烯吲哚酮化物及其用途
|
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
AU2020301161B2
(en)
|
2019-06-25 |
2023-10-26 |
Gilead Sciences, Inc. |
FLT3L-Fc fusion proteins and methods of use
|
|
US11872217B2
(en)
|
2019-07-10 |
2024-01-16 |
Chemocentryx, Inc. |
Indanes as PD-L1 inhibitors
|
|
AU2020315598B2
(en)
|
2019-07-16 |
2024-12-12 |
Gilead Sciences, Inc. |
HIV vaccines and methods of making and using
|
|
WO2021011891A1
(en)
|
2019-07-18 |
2021-01-21 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
|
JP7665593B2
(ja)
|
2019-08-09 |
2025-04-21 |
インサイト・コーポレイション |
Ｐｄ－１／ｐｄ－ｌ１阻害剤の塩
|
|
WO2021034804A1
(en)
|
2019-08-19 |
2021-02-25 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
|
AR120109A1
(es)
|
2019-09-30 |
2022-02-02 |
Incyte Corp |
Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores
|
|
PE20230407A1
(es)
|
2019-11-11 |
2023-03-07 |
Incyte Corp |
Sales y formas cristalinas de un inhibidor de pd-1/pd-l1
|
|
EP4643882A3
(en)
|
2019-11-26 |
2026-01-14 |
Gilead Sciences, Inc. |
Capsid inhibitors for the prevention of hiv
|
|
EP4445902A3
(en)
|
2019-12-24 |
2024-12-18 |
Carna Biosciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
CR20220418A
(es)
|
2020-02-24 |
2022-10-10 |
Gilead Sciences Inc |
Compuestos tetracíclicos para el tratamiento de infecciones por vih
|
|
CA3169348A1
(en)
|
2020-03-20 |
2021-09-23 |
Gilead Sciences, Inc. |
Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
|
|
WO2021236944A1
(en)
|
2020-05-21 |
2021-11-25 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising bictegravir
|
|
JP7520162B2
(ja)
|
2020-06-25 |
2024-07-22 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖの治療のためのカプシド阻害剤
|
|
ES3054072T3
(en)
|
2020-08-07 |
2026-01-29 |
Gilead Sciences Inc |
Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use
|
|
CA3192145A1
(en)
|
2020-09-30 |
2022-04-07 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and uses thereof
|
|
TW202406932A
(zh)
|
2020-10-22 |
2024-02-16 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
|
WO2022099018A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Process of preparing a pd-1/pd-l1 inhibitor
|
|
WO2022099075A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Crystalline form of a pd-1/pd-l1 inhibitor
|
|
TW202233616A
(zh)
|
2020-11-06 |
2022-09-01 |
美商英塞特公司 |
用於製備ｐｄ－１／ｐｄ－ｌ１抑制劑以及其鹽及結晶形式之方法
|
|
JP7659628B2
(ja)
|
2020-11-11 |
2025-04-09 |
ギリアード サイエンシーズ， インコーポレイテッド |
ｇｐ１２０ ＣＤ４結合部位指向性抗体による治療に感受性のＨＩＶ患者を特定する方法
|
|
JP7591155B2
(ja)
|
2021-01-19 |
2024-11-27 |
ギリアード サイエンシーズ， インコーポレイテッド |
置換ピリドトリアジン化合物及びその使用
|
|
TW202313094A
(zh)
|
2021-05-18 |
2023-04-01 |
美商基利科學股份有限公司 |
使用ＦＬＴ３Ｌ—Ｆｃ融合蛋白之方法
|
|
WO2022271650A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
EP4359415A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
US11932634B2
(en)
|
2021-06-23 |
2024-03-19 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
WO2022271659A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2023050007A1
(en)
*
|
2021-09-29 |
2023-04-06 |
Repare Therapeutics Inc. |
N-(5-substituted-[(1,3,4-thiadiazolyl) or (thiazolyl)])(substituted)carboxamide compounds and use thereof for inhibiting human polymerase theta
|
|
JP7765637B2
(ja)
|
2021-12-03 |
2025-11-06 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖウイルス感染症のための治療化合物
|
|
WO2023102523A1
(en)
|
2021-12-03 |
2023-06-08 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
|
PT4440702T
(pt)
|
2021-12-03 |
2025-08-13 |
Gilead Sciences Inc |
Compostos terapêuticos para a infecção pelo vírus do hiv
|
|
TWI856796B
(zh)
|
2022-04-06 |
2024-09-21 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
|
EP4547659A1
(en)
|
2022-07-01 |
2025-05-07 |
Gilead Sciences, Inc. |
Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
|
|
KR20250036855A
(ko)
|
2022-07-12 |
2025-03-14 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 면역원성 폴리펩타이드 및 백신, 및 이들의 용도
|
|
WO2024044477A1
(en)
|
2022-08-26 |
2024-02-29 |
Gilead Sciences, Inc. |
Dosing and scheduling regimen for broadly neutralizing antibodies
|
|
CR20250160A
(es)
*
|
2022-09-29 |
2025-08-06 |
Repare Therapeutics Inc |
Compuestos n-(5-sustituido-[(1,3,4-tiadiazolil) o (1,3-tiazolil)](sustituido) carboxamida, composiciones farmacéuticas y métodos de preparación de los compuestos amida y de su uso
|
|
EP4598934A1
(en)
|
2022-10-04 |
2025-08-13 |
Gilead Sciences, Inc. |
4'-thionucleoside analogues and their pharmaceutical use
|
|
AR132464A1
(es)
|
2023-04-19 |
2025-07-02 |
Gilead Sciences Inc |
Régimen de dosificación de inhibidor de la cápside
|
|
AU2024283382A1
(en)
|
2023-05-31 |
2025-11-13 |
Gilead Sciences, Inc. |
Anti-hiv compounds
|
|
EP4719608A1
(en)
|
2023-05-31 |
2026-04-08 |
Gilead Sciences, Inc. |
Quinazolinyl-indazole derivatives as therapeutic compounds for hiv
|
|
AU2024281548A1
(en)
|
2023-05-31 |
2025-11-13 |
Gilead Sciences, Inc. |
Solid forms of compounds useful in the treatment of hiv
|
|
KR20260046169A
(ko)
|
2023-07-28 |
2026-04-06 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv의 치료 및 예방을 위한 레나카파비르 주간 투여 레지먼
|
|
WO2025042394A1
(en)
|
2023-08-23 |
2025-02-27 |
Gilead Sciences, Inc. |
Dosing regimen of hiv capsid inhibitor
|
|
WO2025076542A1
(en)
|
2023-10-05 |
2025-04-10 |
Jones R Brad |
Atovaquone as an ros inducer for use in the elimination of hiv-infected t-cells
|
|
TW202515549A
(zh)
|
2023-10-11 |
2025-04-16 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
|
CN122055369A
(zh)
|
2023-10-11 |
2026-05-15 |
吉利德科学公司 |
桥连三环氨基甲酰基吡啶酮化合物及其用途
|
|
AU2024360779A1
(en)
|
2023-10-11 |
2026-04-16 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and uses thereof
|
|
US20250230163A1
(en)
|
2023-12-22 |
2025-07-17 |
Gilead Sciences, Inc. |
Solid forms of hiv integrase inhibitors
|
|
US20250296932A1
(en)
|
2024-03-01 |
2025-09-25 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising hiv integrase inhibitors
|
|
US20250333424A1
(en)
|
2024-03-01 |
2025-10-30 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
US20250289822A1
(en)
|
2024-03-01 |
2025-09-18 |
Gilead Sciences, Inc. |
Solid forms of hiv integrase inhibitors
|
|
TW202602461A
(zh)
|
2024-04-03 |
2026-01-16 |
美商基利科學股份有限公司 |
抗ｈｉｖ化合物
|
|
US20260007683A1
(en)
|
2024-06-14 |
2026-01-08 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising hiv integrase inhibitors
|
|
WO2026038155A1
(en)
*
|
2024-08-16 |
2026-02-19 |
Pfizer Inc. |
Substituted pyridine compounds
|
|
WO2026076265A1
(en)
|
2024-10-03 |
2026-04-09 |
Gilead Sciences, Inc. |
Combination therapy comprising bridged tricyclic carbamoylpyridone compounds and p-glycoprotein inhibitors
|